Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection

Autor: Cobos-Campos, R, Apiñaniz, A, Parraza, N, Cordero, J, García, S, Orruño, E

Publikováno v: In Current Research in Translational Medicine October 2021 69(4)

Effectiveness of antidepressants in improving the prognosis of COVID-19: A systematic review and meta-analysis.

Autor: Cobos-Campos R; Bioaraba Health Research Institute, Epidemiology and Public Health Group, Vitoria-Gasteiz, Spain. Electronic address: raquel.coboscampos@osakidetza.eus., de Lafuente-Moríñigo AS; Bioaraba Health Research Institute, Epidemiology and Public Health Group, Vitoria-Gasteiz, Spain., Cordero-Guevara JA; Bioaraba Health Research Institute, Epidemiology and Public Health Group, Vitoria-Gasteiz, Spain., Bermúdez-Ampudia C; Bioaraba Health Research Institute, Epidemiology and Public Health Group, Vitoria-Gasteiz, Spain., Apiñaniz A; Bioaraba Health Research Institute, Epidemiology and Public Health Group, Vitoria-Gasteiz, Spain; Osakidetza Basque Health Service, Aranbizkarra I Health Center, Vitoria-Gasteiz, Spain; Department of Preventive Medicine and Public Health, University of the Basque Country, Vitoria-Gasteiz, Spain., Parraza N; Bioaraba Health Research Institute, Epidemiology and Public Health Group, Vitoria-Gasteiz, Spain.

Publikováno v: Atencion primaria [Aten Primaria] 2024 Mar; Vol. 56 (3), pp. 102771. Date of Electronic Publication: 2023 Nov 28.

Recurrencias loco-regionales en pacientes con cáncer de mama invasivo que presentan 3 ganglios positivos o menos. ¿Está indicada la radioterapia?

Autor: Lasso Varela, A., Cobos Campos, R., Alia Ramos, A.

Publikováno v: In Clinica e Investigacion en Ginecologia y Obstetricia September-October 2012 39(5):203-209

The Impact of Digital Health on Smoking Cessation.

Autor: Cobos-Campos R; Epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain., Cordero-Guevara JA; Epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain., Apiñaniz A; Epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; Osakidetza Basque Health Service, Vitoria-Gasteiz, Spain.; Department of Preventive Medicine and Public Health, University of the Basque Country, Vitoria-Gasteiz, Spain.; Research Network on Chronicity, Primary Care and Health Promotion, Madrid, Spain., de Lafuente AS; Epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain., Bermúdez Ampudia C; Epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain., Argaluza Escudero J; Epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain., Pérez Llanos I; Epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; Osakidetza Basque Health Service, Vitoria-Gasteiz, Spain., Parraza Diez N; Epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; Research Network on Chronicity, Primary Care and Health Promotion, Madrid, Spain.

Publikováno v: Interactive journal of medical research [Interact J Med Res] 2023 Mar 15; Vol. 12, pp. e41182. Date of Electronic Publication: 2023 Mar 15.

Knowledge about COVID-19 and vaccine acceptability among priority groups defined for vaccination: A cross-sectional study in Araba/Alava, Spain, before the vaccination against SARS-CoV-2.

Autor: Parraza-Diez N; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Madrid, Spain., Bermudez-Ampudia C; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain., Cobos-Campos R; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain., Garmendia I; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; Health Department of Basque Government, Vitoria-Gasteiz, Spain., Orruño E; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain., Ojeda E; Health Promotion and Disease Prevention Department. Madrid Salud, Madrid, Spain., Garitano I; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; School of Human Sciences, University of Deusto, Bilbao, Spain., Robledo M; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain., Portu JJ; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain.; University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain., Apiñaniz A; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.; University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.; Osakidetza Basque Health Service, Aranbizkarra I Health Centre, Vitoria-Gasteiz, Spain.

Publikováno v: Vaccine: X [Vaccine X] 2022 Aug; Vol. 11, pp. 100176. Date of Electronic Publication: 2022 Jun 06.